Metraipolis › archive › dc_ad9ea2fc7fb4

Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual — Europe PMC PPR:PPR285734

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR285734
DOI
10.1101/2021.02.17.431704
License (as archived)
CC0-1.0
Archived
2026-11-05T20:59:30.901Z
SHA-256 of the archived text
762a5ee6e7728f9e95c135a7b4458b761a7df5ca5d478ec615861bf058831bfe
Stable URL of this page
https://metraipolis.com/documento/dc_ad9ea2fc7fb4

How to cite

Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual — Europe PMC PPR:PPR285734 — Europe PMC, https://europepmc.org/article/PPR/PPR285734 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ad9ea2fc7fb4 (Metraipolis archive dc_ad9ea2fc7fb4, sha256 762a5ee6e7728f9e95c135a7b4458b761a7df5ca5d478ec615861bf058831bfe)
BibTeX
@misc{dcad9ea2fc7fb4,
  title = {Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual — Europe PMC PPR:PPR285734},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR285734},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ad9ea2fc7fb4; sha256 762a5ee6e7728f9e95c135a7b4458b761a7df5ca5d478ec615861bf058831bfe},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR285734. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Pathogenic mechanisms underlying severe SARS-CoV2 infection remain largely unelucidated. High throughput sequencing technologies that capture genome and transcriptome information are key approaches to gain detailed mechanistic insights from infected cells. These techniques readily detect both pathogen and host-derived sequences, providing a means of studying host-pathogen interactions. Recent studies have reported the presence of host-virus chimeric (HVC) RNA in RNA-seq data from SARS-CoV2 infected cells and interpreted these findings as evidence of viral integration in the human genome as a potential pathogenic mechanism. Since SARS-CoV2 is a positive sense RNA virus that replicates in the cytoplasm it does not have a nuclear phase in its life cycle, it is biologically unlikely to be in a location where splicing events could result in genome integration. Here, we investigated the biological authenticity of HVC events. In contrast to true biological events such as mRNA splicing and genome rearrangement events, which generate reproducible chimeric sequencing fragments across different biological isolates, we found that HVC events across >100 RNA-seq libraries from patients with COVID-19 and infected cell lines, were highly irreproducible. RNA-seq library preparation is inherently error-prone due to random template switching during reverse transcription of RNA to cDNA. By counting chimeric events observed when constructing an RNA-seq library from human RNA and spike-in RNA from an unrelated species, such as fruit-fly, we estimated that ~1% of RNA-seq reads are artifactually chimeric. In SARS-CoV2 RNA-seq we found that the frequency of HVC events was, in fact, not greater than this background “noise”. Finally, we developed a novel experimental approach to enrich SARS-CoV2 sequences from bulk RNA of infected cells. This method enriched viral sequences but did not enrich for HVC events, suggesting that the majority of HVC events are, in all likelihood, artifacts of library construction. In conclusion, our findings indicate that HVC events observed in RNA-sequencing libraries from SARS-CoV2 infected cells are extremely rare and are likely artifacts arising from either random template switching of reverse-transcriptase and/or sequence alignment errors. Therefore, the observed HVC events do not support SARS-CoV2 fusion to cellular genes and/or integration into human genomes.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: bioRxiv, 2021 (prima pubblicazione 2021-02-19).
Identificativi: DOI 10.1101/2021.02.17.431704.
Pagina: https://europepmc.org/article/PPR/PPR285734 — https://doi.org/10.1101/2021.02.17.431704. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T20:48:23.109Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.